Ana Fernandez-Montes
Overview
Explore the profile of Ana Fernandez-Montes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calderon C, Gustems M, Obispo B, Garcia-Garcia T, Hernandez R, Fernandez-Montes A, et al.
Curr Oncol
. 2024 Jun;
31(6):3006-3016.
PMID: 38920713
This study explored the interconnections between sociodemographic elements, depression, fatigue, and exercise in patients suffering from incurable neoplasm, particularly emphasizing the mediating influence of exercise on the relationship between depression...
2.
Riveiro-Barciela M, Carballal S, Diaz-Gonzalez A, Manosa M, Gallego-Plazas J, Cubiella J, et al.
Gastroenterol Hepatol
. 2024 Jan;
47(4):401-432.
PMID: 38228461
The development of the immune checkpoint inhibitors (ICI) is one of the most remarkable achievements in cancer therapy in recent years. However, their exponential use has led to an increase...
3.
Riveiro-Barciela M, Carballal S, Diaz-Gonzalez A, Manosa M, Gallgo-Plazas J, Cubiella J, et al.
Rev Esp Enferm Dig
. 2024 Jan;
116(2):83-113.
PMID: 38226597
The development of the immune checkpoint inhibitors (ICI) is one of the most remarkable achievements in cancer therapy in recent years. However, their exponential use has led to an increase...
4.
Paredero-Perez I, Jimenez-Fonseca P, Cano J, Arrazubi V, Carmona-Bayonas A, Covela-Rua M, et al.
J Geriatr Oncol
. 2023 Nov;
15(3):101657.
PMID: 37957106
Gastric cancer is one of the most frequent and deadly tumours worldwide. However, the evidence that currently exists for the treatment of older adults is limited and is derived mainly...
5.
Lee E, Jimenez-Fonseca P, Galan-Moral R, Coca-Membribes S, Fernandez-Montes A, Sorribes E, et al.
Curr Oncol
. 2023 Oct;
30(10):9205-9216.
PMID: 37887565
The purpose of the study was to identify subgroups of advanced cancer patients who experienced grade 3-4 toxicities as reported by their oncologists as well as identify the demographic, clinical,...
6.
Obispo B, Cruz-Castellanos P, Fernandez-Montes A, Coca-Membribes S, Rogado J, Antonanzas M, et al.
Psychooncology
. 2023 Oct;
32(11):1694-1701.
PMID: 37789602
Purpose: Uncertainty in the context of advanced cancer diagnosis often incurs significant psychological distress. The aims were to evaluate the incidence of psychological distress upon diagnosis of advanced cancer and...
7.
Brozos-Vazquez E, Lago-Leston R, Covela M, de la Camara Gomez J, Fernandez-Montes A, Candamio S, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509239
We aimed to identify common mCRC profiles associated with a discordant mutational status of between the standard of care (SoC) tumour tissue tests and ctDNA tests to understand ctDNA detection...
8.
Psychological factors and prognostic communication preferences in advanced cancer: multicentre study
Ramchandani A, Mihic-Gongora L, Hernandez R, Zafra-Poves M, Munoz M, Ferreira E, et al.
BMJ Support Palliat Care
. 2023 Jul;
13(e3):e1342-e1350.
PMID: 37491146
Objectives: Communication regarding prognosis to patients with advanced cancer is fundamental for informed medical decision making. Our objective was to analyse (1) the proportion of subjects with advanced cancer who...
9.
Lee E, Jimenez-Fonseca P, Hernandez R, Cruz-Castellanos P, Fernandez-Montes A, Rogado J, et al.
Curr Oncol
. 2023 Jun;
30(6):5719-5726.
PMID: 37366912
Financial difficulties experienced by cancer patients negatively impact the mental health of the patients. The objective of this study was to examine the mediating role of financial difficulties between physical...
10.
Carmona-Bayonas A, Rodriguez-Gonzalez A, Garcia-Garcia T, Velasco-Durantez V, Hernandez-San Gil R, Cruz-Castellanos P, et al.
Oncologist
. 2023 May;
28(11):986-995.
PMID: 37185783
Introduction: Anti-neoplastic therapy improves the prognosis for advanced cancer, albeit it is not curative. An ethical dilemma that often arises during patients' first appointment with the oncologist is to give...